From: Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study
Variables | Death (n = 22) | Discharge (n = 102) | P |
---|---|---|---|
Gender | |||
 Male | 14 (63.6) | 55 (53.9) | 0.407 |
Comorbidity | 0.005 | ||
 Without comorbidity | 1 (4.6) | 30 (29.4) |  |
 With single comorbidity | 6 (27.3) | 32 (31.4) |  |
 With multiple comorbidity | 15 (68.1) | 40 (39.2) |  |
 Smoke | 13 (59.1) | 53 (52.0) | 0.545 |
 Panting (breathing rate ≥ 30/min) | 17 (77.3) | 39 (38.2) | 0.001 |
WBC (×109/L) | 0.001 | ||
  >  10 | 10 (45.5) | 14 (13.7) |  |
  ≤ 10 | 12 (54.5) | 88 (86.3) |  |
Lymphocyte (×109/L) | < 0.001 | ||
  > 1.0 | 2 (9.1) | 54 (52.9) |  |
  ≤ 1.0 | 20 (90.9) | 48 (47.1) |  |
Neutrophil (×109/L) | 0.001 | ||
  >  6.3 | 13 (59.1) | 23 (22.6) |  |
  ≤ 6.3 | 9 (40.9) | 79 (77.4) |  |
PLT (×109/L) | 0.076 | ||
  ≥ 100 | 18 (81.8) | 96 (94.1) |  |
  < 100 | 4 (18.2) | 6 (5.9) |  |
CRP (mg/L) | 0.008 | ||
  >  10 | 18 (81.8) | 52 (51.0) |  |
  ≤ 10 | 4 (18.2) | 50 (49.0) |  |
D-dimer (mg/L) | 0.006 | ||
  > 0.55 | 20 (90.9) | 61 (59.8) |  |
  ≤ 0.55 | 2 (9.1) | 41 (40.2) |  |
PCT (ng/ml) | 0.020 | ||
  > 0.05 | 20 (90.9) | 67 (65.7) |  |
  ≤ 0.05 | 2 (9.1) | 35 (34.3) |  |
IL-6 (pg/ml) | < 0.001 | ||
  ≥ 10 | 21 (95.5) | 47 (46.1) |  |
  < 10 | 1 (4.5) | 55 (53.9) |  |
SaO2 on admission | 0.294 | ||
  ≥ 90% | 13 (59.1) | 72 (70.6) |  |
  <  90% | 9 (40.9) | 30 (29.4) |  |
TBIL (μmol/L) | 0.326 | ||
  ≥ 20 | 10 (45.5) | 35 (34.3) |  |
  <  20 | 12 (54.5) | 67 (65.7) |  |
ALT (U/L) | 0.147 | ||
  ≥ 40 | 9 (40.9) | 26 (25.5) |  |
  <  40 | 13 (59.1) | 76 (74.5) |  |
AST (U/L) | 0.213 | ||
  ≥ 40 | 10 (45.5) | 31 (30.4) |  |
  <  40 | 12 (54.5) | 71 (69.6) |  |
LDH (U/L) | 0.352 | ||
  ≥ 245 | 14 (63.6) | 75 (73.5) |  |
  <  245 | 8 (36.4) | 27 (26.5) |  |
γ-GT (U/L) | 0.441 | ||
  ≥ 50 | 13 (59.1) | 51 (50.0) |  |
  <  50 | 9 (40.9) | 51 (50.0) |  |
Cr (μmol/L) | 0.718 | ||
  > 80 | 8 (36.4) | 33 (32.4) |  |
  ≤ 80 | 14 (63.6) | 69 (67.6) |  |